The federal rules for Part 2 programs apply before our current framework for patient privacy thinking, HIPAA. The second part has its origins in the drug revolution of the 1970s. It was necessary to protect drug treatment protocols more strictly than other medical records in order to avoid the stigma of addiction and the fear of those seeking addiction assistance from prosecution. The goal was to encourage people to seek treatment. With the increase in drug abuse, 42 CFR Part 2 has become a hotly debated topic. More recently, the Substance Abuse and Mental Health Services Administration (SAMHSA) has introduced updated provisions that have led Part 2 clinics to review their agreements with outside agencies. The most common agreement between a covered company and its third-party supplier is BAA. BaA is more common than the term QSOA for health care providers, simply because a large majority of the companies covered are not qualified as Part 2 programs and, as a result, covered companies use BAAs much more often than QSOAs. A health care provider who is concerned about the possible interaction with medication and the treatment of a patient in an emergency may also have access to a Part 2 patient`s destos if the physician has signed a QSOA with the patient`s Part 2 program (and the information is limited to what the provider needs to provide services for the Part 2 program) or if the patient obtains the patient`s approval.
[vi] www.hhs.gov/hipaa/for-professionals/covered-entities/sample-business-associate-agreement-provisions/index.html A QSOA is a bilateral agreement between a Part 2 program and the agency that provides the service, in this case the child care provider. The QSOA authorizes communication between these two parties, but the Part 2 program should only provide the QSO with the information necessary to enable QSO to perform its tasks under the QSOA. In addition, the QSOA does not authorize an OQ to disclose information to third parties, unless that third party is a contract agent of the SQO and assists in providing services described in the QSOA, and only as long as the agent only transmits the information to the QSO or the Part 2 program from which the information originates. For more information, see FAQ 10 of the 2010 faQs, published by SAMHSA and the ONC, at: Application of substance abuse privacy rules to the exchange of health information (PDF | 381 KB). No no. A QSOA is a bilateral agreement between a Part 2 program and the entity that provides the service, for example. B a laboratory. The QSOA only allows communication between the Part 2 program and QSO. The QSO, in this case the laboratory, would not be allowed to transmit the laboratory results to another QSO such as an HIO via the Part 2 patient, even though the HIO also signed a QSOA with the Part 2 program. In order for the laboratory to continue to provide the HIO with the patient information in Part 2, the consent signed by the patient must be partially 2 or another part 2 authorization. An authorization form could authorize the Part 2 program to transmit information to the laboratory and authorize the laboratory to transmit Part 2 information to the HIO.
As soon as the HIO receives the results from the laboratory, it can send these results to the Part 2 program through the QSOA it signed with the Part 2 program, provided it is a service described in the QSOA.